Welcome to the CIBMTR Forms Instruction Manual. The Table of Contents on the left side of the screen is for navigational purposes; if you are on a mobile device you may find the Table on Contents on the top of the page.

General Instructions provides useful general background information for successfully completing forms.

2804/2814: CRID Assignment and Indication provides explanatory text used to generate a CIBMTR Research ID (CRID) and report the indication.

Transplant Essential Data (TED) Manuals provides explanatory text for each question found on the TED forms.

Comprehensive Baseline & Follow-up Forms Manuals provides explanatory text for each question on the Baseline, Follow-up, IDMs, HLA, and Infusion forms.

Comprehensive Disease Specific Manuals provides explanatory text and additional information for disease indications requiring CIBMTR reporting.

Cellular Therapy Manuals provides explanatory text for completing pre-infusion, infusion, and post-infusion forms

Infection & Miscellaneous Manuals provides explanatory text for manuals such as the Hepatitis Serology, VOD / SOS, and Myelofibrosis CMS Study forms.

Appendices provide additional information beyond the scope of the other manuals.

Manual Updates:
Sections of the Forms Instruction Manual are frequently updated. In addition to documenting the changes within each manual section, the most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.

Date Manual Section Add/Remove/Modify Description
1/18/2022 Appendix J: Reporting Comorbidities Update Updated arrhythmia criteria to be consistent with the Pre-TED (2400) instructions: Any history of • Atrial fibrillation
• Atrial flutter
• Sick sinus syndrome
• Ventricular arrhythmias
Any history of any type of arrhythmia that has necessitated the delivery of a specific antiarrhythmic agent. Examples include, but are not limited to, atrial fibrillation or flutter, sick sinus syndrome, and ventricular arrhythmias.
1/5/2022 ALL Response Criteria Modify Transfusion independent criteria updated for CRi: Transfusion independent (a minimum of eight weeks without platelet or red blood cell transfusion) (Please note, if the physician documents transfusion dependence related to treatment and not to the patient’s underlying AML, CR-i- should be reported
1/5/2022 AML Response Criteria Modify Transfusion independent criteria updated for CRi: Transfusion independent (a minimum of eight weeks without platelet or red blood cell transfusion) (Please note, if the physician documents transfusion dependence related to treatment and not to the patient’s underlying AML, CR-i- should be reported
Last modified: Jan 18, 2022

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.